A detailed history of King Luther Capital Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, King Luther Capital Management Corp holds 1,460,929 shares of ABT stock, worth $169 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
1,460,929
Previous 1,553,629 5.97%
Holding current value
$169 Million
Previous $161 Million 3.17%
% of portfolio
0.72%
Previous 0.74%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$100.07 - $118.13 $9.28 Million - $11 Million
-92,700 Reduced 5.97%
1,460,929 $167 Million
Q2 2024

Aug 12, 2024

SELL
$100.73 - $112.44 $6.19 Million - $6.91 Million
-61,442 Reduced 3.8%
1,553,629 $161 Million
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $39.6 Million - $43.8 Million
-361,915 Reduced 18.31%
1,615,071 $184 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $7.4 Million - $9.06 Million
-82,091 Reduced 3.99%
1,976,986 $218 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $534,585 - $641,413
-5,596 Reduced 0.27%
2,059,077 $199 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $3.75 Million - $4.17 Million
37,174 Added 1.83%
2,064,673 $225 Million
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $2.94 Million - $3.46 Million
-30,360 Reduced 1.48%
2,027,499 $205 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $1.53 Million - $1.79 Million
-16,066 Reduced 0.77%
2,057,859 $226 Million
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $690,576 - $799,558
-7,137 Reduced 0.34%
2,073,925 $201 Million
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $2.99 Million - $3.62 Million
-29,315 Reduced 1.39%
2,081,062 $226 Million
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $1.65 Million - $2.01 Million
-14,433 Reduced 0.68%
2,110,377 $250 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $3.9 Million - $4.77 Million
-33,741 Reduced 1.56%
2,124,810 $299 Million
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $1.57 Million - $1.74 Million
13,468 Added 0.63%
2,158,551 $255 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $5.34 Million - $6.29 Million
-50,506 Reduced 2.3%
2,145,083 $249 Million
Q1 2021

May 12, 2021

SELL
$108.84 - $128.23 $3.04 Million - $3.58 Million
-27,909 Reduced 1.26%
2,195,589 $263 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $579,285 - $631,255
5,517 Added 0.25%
2,223,498 $243 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $1.13 Million - $1.37 Million
-12,314 Reduced 0.55%
2,217,981 $241 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $2.41 Million - $3.09 Million
-31,524 Reduced 1.39%
2,230,295 $204 Million
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $1.08 Million - $1.58 Million
17,226 Added 0.77%
2,261,819 $178 Million
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $2.49 Million - $2.78 Million
31,771 Added 1.44%
2,244,593 $195 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $2.14 Million - $2.33 Million
26,206 Added 1.2%
2,212,822 $185 Million
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $1.78 Million - $2.08 Million
24,454 Added 1.13%
2,186,616 $184 Million
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $1.27 Million - $1.53 Million
19,107 Added 0.89%
2,162,162 $173 Million
Q4 2018

Feb 12, 2019

BUY
$65.56 - $74.27 $4.96 Million - $5.62 Million
75,631 Added 3.66%
2,143,055 $155 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $700,470 - $845,033
11,519 Added 0.56%
2,067,424 $152 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $3 Million - $3.31 Million
-52,170 Reduced 2.47%
2,055,905 $125 Million
Q1 2018

May 08, 2018

BUY
$56.27 - $63.62 $123,794 - $139,964
2,200 Added 0.1%
2,108,075 $126 Million
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $11.2 Million - $12 Million
209,529 Added 11.05%
2,105,875 $120 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $91.1 Million - $102 Million
1,896,346
1,896,346 $101 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.